The 2000 United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) inhibitor guidelines.
The UKHCDO inhibitor guidelines address the diagnosis and management of patients with haemophilia A, haemophilia B and acquired haemophilia. Recommendations are based on best current practice as reflected in the published evidence base. Many current treatment strategies are based on uncontrolled observations highlighting the need for well designed controlled studies.
Hay
C R M
CR
Manchester Thrombosis and Haemostasis Centre, Manchester, UK. haemophilia@man.ac.uk
D001323:Autoantibodies / Q000097:blood; D001779:Blood Coagulation Factors / Q000276:immunology / Q000627:therapeutic use; D006467:Hemophilia A / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy*; D006470:Hemorrhage / Q000209:etiology / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance; D007518:Isoantibodies / Q000097:blood
D001323:Autoantibodies; D001779:Blood Coagulation Factors; D007518:Isoantibodies